[Factor VIII inhibitors]. 1968

M I Albores Núñez, and J A Pérez Llanderal, and A Telenti Vigón

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D013925 Thromboplastin Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation. Antigens, CD142,CD142 Antigens,Coagulation Factor III,Factor III,Tissue Factor,Tissue Thromboplastin,Blood Coagulation Factor III,Coagulin,Glomerular Procoagulant Activity,Prothrombinase,Tissue Factor Procoagulant,Urothromboplastin,Activity, Glomerular Procoagulant,Factor III, Coagulation,Procoagulant Activity, Glomerular,Procoagulant, Tissue Factor,Thromboplastin, Tissue

Related Publications

M I Albores Núñez, and J A Pérez Llanderal, and A Telenti Vigón
January 2001, Advances in experimental medicine and biology,
M I Albores Núñez, and J A Pérez Llanderal, and A Telenti Vigón
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
M I Albores Núñez, and J A Pérez Llanderal, and A Telenti Vigón
April 1995, Haemophilia : the official journal of the World Federation of Hemophilia,
M I Albores Núñez, and J A Pérez Llanderal, and A Telenti Vigón
October 1993, Lancet (London, England),
M I Albores Núñez, and J A Pérez Llanderal, and A Telenti Vigón
October 1993, Lancet (London, England),
M I Albores Núñez, and J A Pérez Llanderal, and A Telenti Vigón
September 1995, Current opinion in hematology,
M I Albores Núñez, and J A Pérez Llanderal, and A Telenti Vigón
January 1977, La Ricerca in clinica e in laboratorio,
M I Albores Núñez, and J A Pérez Llanderal, and A Telenti Vigón
July 1997, Thrombosis and haemostasis,
M I Albores Núñez, and J A Pérez Llanderal, and A Telenti Vigón
July 2008, Blood,
M I Albores Núñez, and J A Pérez Llanderal, and A Telenti Vigón
July 1974, The New England journal of medicine,
Copied contents to your clipboard!